TY - GEN
T1 - Inhibition of c-Jun N-terminal kinase pathway attenuates cerebral vasospasm after experimental subarachnoid hemorrhage through the suppression of apoptosis
AU - Yatsushige, H.
AU - Yamaguchi-Okada, M.
AU - Zhou, C.
AU - Calvert, J. W.
AU - Cahill, J.
AU - Colohan, A. R.T.
AU - Zhang, John H.
N1 - Recent studies have demonstrated that apoptosis in cerebral arteries could play an essential role in cerebral vasospasm after subarachnoid hemorrhage (SAH) and that SP600125, an inhibitor of c-Jun N-t
PY - 2008/3/25
Y1 - 2008/3/25
N2 - Recent studies have demonstrated that apoptosis in cerebral arteries could play an essential role in cerebral vasospasm after subarachnoid hemorrhage (SAH) and that SP600125, an inhibitor of c-Jun N-terminal kinase (JNK) could suppress apoptosis. The present study examined whether SP600125 could reduce cerebral vasospasm through the suppression of apoptosis. Fifteen dogs were assigned to 3 groups: control, SAH, and SAH+SP600125 (30 μmol/l). SAH was induced by the injection of autologous blood into the cisterna magna on day 0 and day 2. Angiograms were evaluated on day 0 and day 7. The activation of the JNK pathway and caspase-3 were also evaluated using Western blot. To determine the distribution, TUNEL staining and immunohistochemistry for phosphorylated c-jun and cleaved caspase-3 were performed. Severe vasospasm was observed in the basilar artery of the SAH dogs. SP600125 reduced angiographic and morphological vasospasm and reduced the expression of cleaved caspase-3, thereby suppressing apoptosis. These results demonstrate that SP600125 attenuates cerebral vasospasm through the suppression of apoptosis, which may provide a novel therapeutic target for cerebral vasospasm. © 2008 Springer-Verlag.
AB - Recent studies have demonstrated that apoptosis in cerebral arteries could play an essential role in cerebral vasospasm after subarachnoid hemorrhage (SAH) and that SP600125, an inhibitor of c-Jun N-terminal kinase (JNK) could suppress apoptosis. The present study examined whether SP600125 could reduce cerebral vasospasm through the suppression of apoptosis. Fifteen dogs were assigned to 3 groups: control, SAH, and SAH+SP600125 (30 μmol/l). SAH was induced by the injection of autologous blood into the cisterna magna on day 0 and day 2. Angiograms were evaluated on day 0 and day 7. The activation of the JNK pathway and caspase-3 were also evaluated using Western blot. To determine the distribution, TUNEL staining and immunohistochemistry for phosphorylated c-jun and cleaved caspase-3 were performed. Severe vasospasm was observed in the basilar artery of the SAH dogs. SP600125 reduced angiographic and morphological vasospasm and reduced the expression of cleaved caspase-3, thereby suppressing apoptosis. These results demonstrate that SP600125 attenuates cerebral vasospasm through the suppression of apoptosis, which may provide a novel therapeutic target for cerebral vasospasm. © 2008 Springer-Verlag.
KW - Cerebral vasospasm
KW - JNK
KW - apoptosis
KW - subarachnoid hemorrhage
KW - Vasospasm, Intracranial/pathology
KW - Apoptosis/drug effects
KW - Anthracenes/therapeutic use
KW - JNK Mitogen-Activated Protein Kinases/antagonists & inhibitors
KW - Animals
KW - Basilar Artery/drug effects
KW - Dogs
KW - Subarachnoid Hemorrhage/pathology
KW - Disease Models, Animal
UR - https://www.scopus.com/pages/publications/85052610459
UR - https://www.scopus.com/pages/publications/85052610459#tab=citedBy
UR - https://www.mendeley.com/catalogue/6c57c015-c858-3eba-981a-2f0e0bf800cd/
U2 - 10.1007/978-3-211-75718-5_6
DO - 10.1007/978-3-211-75718-5_6
M3 - Conference contribution
C2 - 18456994
SN - 9783211757178
SN - 978-3-211-99916-5
T3 - Acta Neurochirurgica, Supplementum
SP - 27
EP - 31
BT - Cerebral Vasospasm
PB - Springer Vienna
ER -